SEC ownership of EXOZYMES INC.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0002010788.

Comparable stake leader

MDB Capital Holdings, LLC

Disclosed value leader

MDB Capital Holdings, LLC

Comparable rows

0/18

Latest evidence

09 Apr 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 1 signal
Latest parsed ownership date
09 Apr 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0002010788
Issuer location
Monrovia, CA

Ownership snapshot

Top shareholders of EXOZYMES INC. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
MDB Capital Holdings, LLC
Disclosed value leader
MDB Capital Holdings, LLC
Comparable rows
0/18
Latest evidence
09 Apr 2026
3/4/5 13F Highest disclosed value: $25,159,251 18 rows are not safely comparable across share classes. Showing 1-8 of 18 holder rows.

Quick read

MDB Capital Holdings, LLC has the largest disclosed position value at $25.16M.

0 of 18 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MDB Capital Holdings, LLC's linked filing trail.
Disclosed position value Top 5
MDB Capital Holdings, LLC $25.16M
Anthony DiGiandomenico $24.37M
Christopher A. Marlett $24.37M
Tyler Paz Korman $7.67M
Paul Hideo Opgenorth $7.03M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-8 of 18 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
MDB Capital Holdings, LLC
3/4/5
10%+ Owner
class O/S missing
$25,159,251
3,931,133 shares
08 Nov 2024
Anthony DiGiandomenico
3/4/5
Director, 10%+ Owner
class O/S missing
$24,374,246
3,808,476 shares
08 Nov 2024
Christopher A. Marlett
3/4/5
Director, 10%+ Owner
class O/S missing
$24,374,246
3,808,476 shares
08 Nov 2024
Tyler Paz Korman
3/4/5
Chief Scientific Officer
class O/S missing
$7,674,019
729,123 shares
-$15,424 09 Apr 2026
Paul Hideo Opgenorth
3/4/5
Vice President, Development
class O/S missing
$7,032,124
645,149 shares
01 Apr 2026
James U. Bowie
3/4/5
Director
class O/S missing
$3,698,624
577,910 shares
08 Nov 2024
Mohammad Hayat
3/4/5
President & Chairman of Board, Director
class O/S missing
$997,235
155,818 shares
08 Nov 2024
Edgardo Javier Rayo
3/4/5
Director
class O/S missing
$839,859
77,909 shares
17 Feb 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$4,795.

Buys
$10,629
Insiders: 1
Sells
$15,424
Insiders: 1
Net
-$4,795
Shares: -460
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 1,040 Shares: 1,500
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 1,500 $0 $15,424 -$15,424
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 1,040 0 $10,629 $0 +$10,629

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-13 of 13 reporting-owner rows connected to EXOZYMES INC.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
13
Largest Forms 3/4/5 holder
MDB Capital Holdings, LLC
Net 12M change
-$4,795
Latest report
09 Apr 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
MDB Capital Holdings, LLC 10%+ Owner $25,159,251 Mixed 08 Nov 2024
Christopher A. Marlett Director, 10%+ Owner $24,374,246 Mixed 08 Nov 2024
Anthony DiGiandomenico Director, 10%+ Owner $24,374,246 Mixed 08 Nov 2024
Tyler Paz Korman Chief Scientific Officer $7,674,019 -$15,424 -0.2% Filing P/S 09 Apr 2026
Paul Hideo Opgenorth Vice President, Development $7,032,124 Mixed 01 Apr 2026
James U. Bowie Director $3,698,624 Mixed 08 Nov 2024
Mohammad Hayat President & Chairman of Board, Director $997,235 Mixed 08 Nov 2024
Edgardo Javier Rayo Director $839,859 Mixed 17 Feb 2025
Michael Heltzen Chief Executive Officer $108,626 +$10,629 +11% Filing P/S 02 Jul 2025
Fouad Nawaz Vice President- Finance $103,419 Mixed 01 Apr 2026
Damien Alan Perriman Chief Commercial Officer $0 Mixed 01 Apr 2026
James J. Lalonde Director Mixed 08 Nov 2024
Lon Edward Bell Director Mixed 08 Nov 2024

Recent insider transactions for EXOZYMES INC.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Tyler Paz Korman EXOZ COMMON STOCK Sale -0.1% $7,894 $10.52 -750 729,123 09 Apr 2026 Direct
Tyler Paz Korman EXOZ COMMON STOCK Sale -0.1% $7,530 $10.04 -750 729,873 08 Apr 2026 Direct
Damien Alan Perriman EXOZ Restricted Stock Grant for Common Stock Award 62,759 62,759 01 Apr 2026 Direct
Damien Alan Perriman EXOZ Stock Option for Common Stock Award 146,437 146,437 01 Apr 2026 Direct
Damien Alan Perriman EXOZ COMMON STOCK Award 8,887 0 01 Apr 2026 Direct
Paul Hideo Opgenorth EXOZ COMMON STOCK Award 0.62% 3,999 645,149 01 Apr 2026 Direct
Fouad Nawaz EXOZ COMMON STOCK Award 171.9% 5,999 9,488 01 Apr 2026 Direct
Tyler Paz Korman EXOZ COMMON STOCK Award 0.74% 5,332 730,623 01 Apr 2026 Direct
Michael Heltzen EXOZ Common Stock Purchase 10.8% $10,629 $10.22 1,040 10,629 02 Jul 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .